Evicenter
MarkdownMedical informationP&T meetings
Inaxaplin (VX-147)

APOL1-mediated kidney disease

Launch
Not announced
Last updated
162 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology

Incidence of APOL1-mediated kidney disease

9 evidence topics · 12 sources

Penetrance: lifetime risk of CKD, kidney failure, FSGS, and HIVAN among genotype carriers